Cyr61: a potential therapeutic target for prostate cancer

Asian J Androl. 2014 Sep-Oct;16(5):788-9. doi: 10.4103/1008-682X.128517.

Authors

Chang-Ming Lin, Chao-Zhao Liang¹

Affiliation

¹ Department of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Biomarkers, Tumor / metabolism*
Cysteine-Rich Protein 61 / metabolism*
Humans
Male
Prostatic Neoplasms / diagnosis*

Substances

Biomarkers, Tumor
Cysteine-Rich Protein 61